Results 81 to 90 of about 33,778 (258)

Correspondence of PPP4C localization with many known SLE autoantigens.

open access: yes, 2014
Primary autoantigens are in bold.
Kenneth Andrew Ross (591738)
core   +1 more source

Pathogen‐specific B‐cell receptors drive chronic lymphocytic leukemia by light‐chain‐dependent cross‐reaction with autoantigens

open access: yesEMBO Molecular Medicine, 2017
Several lines of evidence indirectly suggest that antigenic stimulation through the B‐cell receptor (BCR) supports chronic lymphocytic leukemia (CLL) development.
Nereida Jiménez de Oya   +12 more
doaj   +1 more source

Impact of Lymphocyte Apoptosis in Diabetes mellitus

open access: yesAsian Journal of Medical Sciences, 2011
Diabetes mellitus is a metabolic disorder. It is the most common cause of blindness, kidney failure, and amputations in adults and a leading cause of heart disease and stroke.
Awadhesh K Arya
doaj   +1 more source

Increased anergic B cells and decreased antibody‐secreting cells during romiplostim treatment in patients with immune thrombocytopenia

open access: yesBritish Journal of Haematology, EarlyView.
Summary Patients with immune thrombocytopenia (ITP) exhibit substantial heterogeneity in treatment responses. Approximately 30%–50% of patients maintain remission after discontinuation of thrombopoietin receptor agonists (TPO‐RA), suggesting immunomodulatory effects beyond enhanced thrombopoiesis.
Vivianne S. Nelson   +5 more
wiley   +1 more source

Candidate autoantigens specifically bound to ACPA*.

open access: yes, 2016
Candidate autoantigens specifically bound to ACPA*.
Peyman Ezzati (353473)   +5 more
core   +1 more source

Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren’s syndrome

open access: yesAutoimmunity, 2019
Salivary and lacrimal gland involvement is a characteristic feature of primary Sjögren’s syndrome (pSS), where tissue destruction is mediated by mononuclear cell infiltration, resulting in lacrimal and salivary gland impairment.
Kathrine Skarstein   +5 more
doaj   +1 more source

Cardiac surveillance in immune checkpoint inhibitor therapy: Insights from the Essen Cardio‐oncology Registry

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Immune checkpoint inhibitors (ICI) have revolutionized cancer therapy, offering improvements in survival across various malignancies. However, their toxicities pose a major challenge for cardio‐oncology units. Despite their growing importance, data on effectiveness of such specialized units in mitigating ICI‐associated ...
Elias Haj‐Yehia   +6 more
wiley   +1 more source

List of candidate NPSLE autoantigens identified by proteome microarray.

open access: yes, 2016
List of candidate NPSLE autoantigens identified by proteome microarray.
Wei Huang (36889)   +10 more
core   +1 more source

Cardiovascular toxicity from immune checkpoint inhibitor therapy: an inflammatory continuum

open access: yesBritish Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI) therapy has markedly improved outcomes in advanced malignancies but has also revealed a distinct spectrum of cardiovascular immune‐related adverse events. Myocarditis represents the most severe manifestation, while non‐inflammatory left ventricular dysfunction and vascular inflammation have emerged as additional ...
Fabrice Reyes   +7 more
wiley   +1 more source

Autoantigens identified using sera from psoriasis vulgaris patients.

open access: yes, 2014
Autoantigens identified using sera from psoriasis vulgaris patients.
Yasuyuki Amoh (423988)   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy